Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study.
Abstract
Background: Annualized relapse rate (ARR) is used as an outcome measure in multiple sclerosis (MS) clinical trials. Previous studies demonstrated that ARR has reduced in placebo groups between 1990 and 2012. This study aimed to estimate real-world ARRs from contemporary MS clinics in the UK, in order to improve the feasibility estimations for clinical trials and facilitate MS service planning.
Citations
Altmetric:
Date
2023-05-20
Type
Article
Subject
Neurology
Collections
Citation
Neurol Sci . 2023 Oct;44(10):3629-3635
Journal / Source Title
Neurological Sciences
DOI
10.1007/s10072-023-06838-1
PMID
37208584
Publisher
Springer
Publisher’s URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198787/